Aspiriant LLC Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$60.8M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$11M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$8.17M |
| 4 |
Fidelity Total Bond ETF
FBND
|
+$7.12M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$6.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$14.2M |
| 2 |
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
|
+$3.83M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.23M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$3.04M |
| 5 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$2.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.68% |
| 2 | Financials | 2.64% |
| 3 | Communication Services | 1.25% |
| 4 | Healthcare | 1.06% |
| 5 | Consumer Discretionary | 0.85% |
Similar funds
Aspiriant LLC's Q4 2023 Portfolio in Review
As of Q4 2023, Aspiriant LLC held 318 positions worth $2.22B, up 14% from $1.95B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Aspiriant LLC deployed $98.1M of net new capital in Q4 2023, opening 36 new positions and adding to 96 existing holdings. Its largest new stake was iShares MSCI Global Sustainable Development Goals ETF: 35,305 shares worth $2.86M.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 6.1% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was iShares MSCI Global Min Vol Factor ETF, an estimated $14.2M trimmed.
- Aspiriant LLC's largest Q4 2023 buy was iShares MSCI Global Sustainable Development Goals ETF: 35,305 shares worth $2.86M.
- Aspiriant LLC added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2023, an estimated $60.8M increase.
- Aspiriant LLC's biggest Q4 2023 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $14.2M.
- Aspiriant LLC fully exited Lam Research in Q4 2023, selling an estimated $239K.
- Aspiriant LLC's ten largest holdings make up 62% of its $2.22B portfolio in Q4 2023.
- Aspiriant LLC opened 36 new positions and closed 10 in Q4 2023.
- Aspiriant LLC's portfolio value rose 14% quarter-over-quarter to $2.22B.
Based on Aspiriant LLC's 13F filing for Q4 2023, filed 26 Jan 2024.